Further to this, several studies have demonstrated that HDAC inhibition can increase the immunogenicity of tumour cells by up-regulating expression of major histocompatibility complex (MHC) proteins and co-stimulatory molecules such as CD40 on the surface of tumour cells, whilst downregulating the expression of anti-apoptotic proteins [102,103,104]. Here, HDAC9 is linked to neoplasm.